Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Jump to: 2021 | 2019 | 2018 | 2017 | 2014
Number of items: 5.

2021

Hedderich, Dennis M., Keicher, Matthias, Wiestler, Benedikt ORCID: 0000-0002-2963-7772, Gruber, Martin J., Burwinkel, Hendrik, Hinterwimmer, Florian ORCID: 0000-0002-0273-0643, Czempiel, Tobias, Spiro, Judith E., Pinto dos Santos, Daniel ORCID: 0000-0003-4785-6394, Heim, Dominik ORCID: 0000-0001-8463-1544, Zimmer, Claus, Rueckert, Daniel, Kirschke, Jan S. and Navab, Nassir (2021). AI for Doctors-A Course to Educate Medical Professionals in Artificial Intelligence for Medical Imaging. Healthcare, 9 (10). BASEL: MDPI. ISSN 2227-9032

2019

Michel, Christian, Burchert, Andreas, Hochhaus, Andreas, Saussele, Susanne, Neubauer, Andreas, Lauseker, Michael, Krause, Stefan W., Kolb, Hans-Jochem, Hossfeld, Dieter Kurt, Nerl, Christoph, Baerlocher, Gabriela M., Heim, Dominik, Bruemmendorf, Tim H., Fabarius, Alice, Haferlach, Claudia, Schlegelberger, Brigitte, Balleisen, Leopold, Goebeler, Maria-Elisabeth, Haenel, Mathias, Ho, Anthony, Dengler, Jolanta, Falge, Christiane, Moehle, Robert, Kremers, Stephan, Kneba, Michael, Stegelmann, Frank, Koehne, Claus-Henning, Lindemann, Hans-Walter, Waller, Cornelius F., Spiekermann, Karsten, Berdel, Wolfgang E., Mueller, Lothar, Edinger, Matthias, Mayer, Jiri, Beelen, Dietrich W., Bentz, Martin, Link, Hartmut, Hertenstein, Bernd, Fuchs, Roland, Wernli, Martin, Schlegel, Frank, Schlag, Rudolf, de Wit, Maike, Truemper, Lorenz, Hebart, Holger, Hahn, Markus, Thomalla, Joerg, Scheid, Christof, Schafhausen, Philippe, Verbeek, Walter, Eckart, Michael J., Gassmann, Winfried, Schenk, Michael, Brossart, Peter, Wuendisch, Thomas, Geer, Thomas, Bildat, Stephan, Schaefer, Erhardt, Hasford, Joerg, Hehlmann, Ruediger and Pfirrmann, Markus (2019). Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV. Haematologica, 104 (5). S. 955 - 963. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

2018

Kroeger, Nicolaus, Iacobelli, Simona, Koster, Linda, Niederwieser, Dietger, Platzbecker, Uwe, Huebel, Kai, Scheid, Christoph, Weber, Thomas, Stelljes, Matthias, Afanasiev, Boris, Heim, Dominik, Deliliers, Giorgio Lambertenghi, Onida, Francesco, Dreger, Peter, Pini, Massimo, Guidi, Stefano, Volin, Liisa, Guenther, Andreas, Bethge, Wolfgang, Poire, Xavier, Kobbe, Guido, van Os, Marleen, Yakoub-Agha, Ibrahim and Robin, Marie (2018). Reduced Intensity Vs. Myeloablative Conditioning Followed By Allogeneic Stem Cell Transplantation for Patients with Myelodysplastic Syndrome: Long Term Follow-up of a Prospective Randomized EBMT Phase III Study (RICMAC-Trial). Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

2017

Kroeger, Nicolaus, Iacobelli, Simona, Franke, Georg-Nikolaus, Platzbecker, Uwe, Uddin, Ruzena, Huebel, Kai, Scheid, Christof, Weber, Thomas, Robin, Marie ORCID: 0000-0003-1388-9876, Stelljes, Matthias, Afanasyev, Boris, Heim, Dominik, Deliliers, Giorgio Lambertenghi, Onida, Francesco ORCID: 0000-0002-2991-3474, Dreger, Peter, Pini, Massimo, Guidi, Stefano, Volin, Liisa ORCID: 0000-0002-9731-8335, Guenther, Andreas, Bethge, Wolfgang, Poire, Xavier, Kobbe, Guido, van Os, Marleen, Brand, Ronald and de Witte, Theo (2017). Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome: A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial). J. Clin. Oncol., 35 (19). S. 2157 - 2167. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

2014

Kroeger, Nicolaus, Brand, Ronald, Niederwieser, Dietger, Platzbecker, Uwe, Huebel, Kai, Weber, Thomas, Robin, Marie, Stelljes, Matthias, Afanasiev, Boris V., Heim, Dominik, Deliliers, Giorgio Lambertenghi, Onida, Francesco, Dreger, Peter, Pini, Massimo, Guidi, Stefano, Volin, Liisa, Gramatzki, Martin, Bethge, Wolfgang A., Poire, Xavier, Kobbe, Guido, van Os, Marleen, Iacobelli, Simona and de Witte, Theo (2014). Reduced Intensity Vs. Standard Conditioning Followed By Allogeneic Stem Cell Transplantation for Patients with MDS or Secondary AML: A Prospective, Randomized Phase III Study of the Chronic Malignancies Working Party of the EBMT (RICMAC-Trial). Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

This list was generated on Sat Apr 27 16:43:37 2024 CEST.